Movetis
Movetis is focused on the development of drugs for the treatment of diseases in the gastrointestinal area.
Launch date
Employees
Market cap
-
Enterprise valuation
€514m (Public information from Aug 2010)
Company register number 0885.206.558
Antwerp Province of Antwerp (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|
| EBITDA | <1m | - | - | - |
| Profit | 59.2m | 2.0m | <1m | 1.1m |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | - | ||
€49.0m | Series A | ||
$565m Valuation: $565m | Acquisition | ||
| Total Funding | €49.0m | ||
Related Content
Recent News about Movetis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.